Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

Last updated: July 22, 2020
Sponsor: Vivozon, Inc.
Overall Status: Active - Recruiting

Phase

3

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04430088
VVZ149-POP-P3-US005
  • Ages > 18
  • All Genders

Study Summary

The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Men and women must be at least 18 years of age. Female subjects must meet additionalcriteria in relation to childbearing potential.

  • Subjects must be undergoing a planned first metatarsal bunionectomy with osteotomy andinternal fixation (Austin bunionectomy) without collateral procedures.

  • Subjects must have the ability to provide written informed consent.

  • Subjects must have the ability to understand study procedures and communicate clearlywith the Investigator and staff.

Exclusion

Key Exclusion Criteria:

  • Subjects undergoing emergency or unplanned surgery.

  • Subjects who had any previous bunionectomy procedure on either foot.

  • Subjects with pre-existing conditions (other than bunion) causing preoperative pain atthe site of surgery.

  • Female subjects who are pregnant or breastfeeding.

  • Diagnosis of chronic pain and ongoing or frequent use of pain medications.

Study Design

Total Participants: 300
Study Start date:
June 26, 2020
Estimated Completion Date:
January 31, 2021

Connect with a study center

  • Arizona Clinical Trial Site

    Phoenix, Arizona 85053
    United States

    Active - Recruiting

  • California Clinical Trial Site

    Anaheim, California 92801
    United States

    Active - Recruiting

  • Texas Clinical Trial Site

    San Antonio, Texas 78229
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.